The University of Cincinnati will cancel all classes on the Uptown and Medical campuses at 11:00 a.m. today including all classes in session at that time. Offices on these campuses also will close at 11:00 a.m. More Information
William “Bill” P. Wiesmann, MD – UC Alumnus, College of Arts & Sciences, BA Chemistry 1968
Personal Note: My undergraduate experience at the University of Cincinnati not only helped shaped my career path, but opened a world of knowledge in literature, economics, art history, anthropology and sociology that has influenced me in profound and important ways. There is not a day in my life that those early courses have not affected the way I view life, history, science and literature and most importantly, the way I learned how to think. My UC Arts and Sciences experience not only taught me the requisites needed for a medical education but made me a better person, more aware of the magnitude of human experience and the stark realization of the connectivity of all knowledge. These life long learning tools have served me well, and for me, the learning has never stopped.
Now as an alumnus, I want to share my life experience and contribute in any way to mentor and encourage undergrads in A & S to actively pursue educational and research opportunities. This learning process will lead UC grads to new opportunities that will fuel their lives the way UC did for me. I am a proud UC graduate and proudly Cincinnati!
Career Achievements: Dr. Wiesmann is the President and Founder of several small biotech companies collectively called the BioSTAR Group, a collection of companies specializing in lifesaving advances in equipment and technologies.
Dr. Wiesmann is co-founder of HemCon Medical Technologies, AutoMedx, Inc., Tissue Genesis, Inc. and Synedgen Inc. HemCon bandages have been credited for saving the lives of thousands of US military troops. The HemCon® bandage was recognized as one of the Top 10 Greatest Inventions by the US Army in 2004. AutoMedx is the developer of advanced prehospital ventilators used by the U.S. military to treat soldiers downrange. Tissue Genesis is a tissue engineering company utilizing stem cell biology to treat a variety of medical needs. Synedgen is a medical technology company developing pharmaceuticals to treat drug-resistant organisms.
Dr. Wiesmann served as the Director for Combat Casualty Care at the US Army Medical Research and Material Command Post, at Ft. Detrick in Frederick, Maryland until he retired from the Army as a Colonel in 1997. Throughout his career, Dr. Wiesmann has garnered extensive business expertise, including formation of R&D partnerships and teaming agreements between government, industry, and academic laboratories, as well as directing multi-million dollar programs for DARPA, NASA, and the Army Medical Research and Material Command. Dr. Wiesmann has successfully led or assisted in taking six medical products successfully through FDA approval to the market and has overseen simultaneous multi-million dollar awards on development of medical products with successful performance and delivery. Dr. Wiesmann has been published in over 70 scientific publications, authored 5 book chapters and has 45 patents awarded and pending.
Educational Highlights: Dr. Wiesmann graduated from the University of Cincinnati with a BA (Cum Laude) in Chemistry from the College of Arts and Sciences in 1968. He graduated with an MD from Washington University in St. Louis in 1972.
Dr Wiesmann completed a medical internship and residency at Barnes Hospital in St. Louis followed by a research and clinical fellowship in Nephrology at Washington University. He completed a second two-year fellowship at the National Heart Lung and Blood Institute at the National Institutes of Health in 1978. Dr Wiesmann began his clinical and research career at the Walter Reed Army Institute of Research in 1978.
In 2008, Dr. Wiesmann was awarded an Honorary Doctor of Science from the University of Cincinnati. Dr. Wiesmann is a member of UC’s Biomedical Engineering Advisory Board, and a member of the National Council at the Washington University School of Medicine. He actively consults on issues of research, policy and programs for CIMIT (Center for Integration of Medicine and Innovative Technology), Massachusetts General Hospital, the Defense Advanced Research Projects Agency, and the Advanced Prosthetics program at Johns Hopkins University Applied Physics Laboratory. He previously served as Chairman of the Scientific Advisory Board of the National Tissue Engineering Center, the Board of Councilors at the University of Southern California Viterbi School of Engineering, and the Board of Trustees at Harvey Mudd College.